Related Experiment Video
Updated: Jul 18, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT
Chetan Bettegowda1, Xin Huang, Jimmy Lin
1The Howard Hughes Medical Institute, The Ludwig Center for Cancer Genetics & Therapeutics, The Sidney Kimmel Comprehensive Cancer Center, Department of Pharmacology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Abstract:
Bacteriolytic anti-cancer therapies employ attenuated bacterial strains that selectively proliferate within tumors. Clostridium novyi-NT spores represent one of the most promising of these agents, as they generate potent anti-tumor effects in experimental animals. We have determined the 2.55-Mb genomic sequence of C. novyi-NT, identifying a new type of transposition and 139 genes that do not have homologs in other bacteria. The genomic sequence was used to facilitate the detection of transcripts expressed at various stages of the life cycle of this bacterium in vitro as well as in infections of tumors in vivo. Through this analysis, we found that C. novyi-NT spores contained mRNA and that the spore transcripts were distinct from those in vegetative forms of the bacterium.
Insights
This study sequenced the Clostridium novyi-NT genome, revealing novel genes and transposition. Researchers discovered that C. novyi-NT spores contain unique mRNA, distinct from vegetative forms, advancing cancer therapy research.
Area of Science:
- Microbiology
- Genomics
- Cancer Therapy
Background:
- Bacteriolytic anti-cancer therapies utilize attenuated bacterial strains for tumor targeting.
- Clostridium novyi-NT spores show significant anti-tumor effects in preclinical models.
Purpose of the Study:
- To determine the complete genomic sequence of Clostridium novyi-NT.
- To identify novel genes and genetic elements within C. novyi-NT.
- To analyze gene expression during different life cycle stages and in tumor infections.
Main Methods:
- Whole-genome sequencing of Clostridium novyi-NT.
- Bioinformatic analysis to identify genes and novel transposition events.
- Transcriptome analysis (RNA sequencing) of C. novyi-NT in vitro and in vivo.
Main Results:
- The 2.55-Mb genome of C. novyi-NT was sequenced, revealing a novel transposition type and 139 unique genes.
- Transcriptome analysis identified distinct mRNA populations in spores versus vegetative C. novyi-NT cells.
- Gene expression patterns were characterized across various life cycle stages and during tumor colonization.
Conclusions:
- The genomic and transcriptomic data provide a foundation for understanding C. novyi-NT biology.
- The discovery of spore-specific transcripts has implications for developing targeted bacterial cancer therapies.
- Further research into C. novyi-NT's unique genetic makeup can optimize its therapeutic potential.
More Related Videos
Related Concept Videos
Genome Size and the Evolution of New Genes
The Antiviral System of Bacteria and Archaea: CRISPR
Genomic DNA in Eukaryotes
Leaky Scanning
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

